ment of anatomically fixed bowel parts showed good recognition by MRE. With increasing CRP values, we found more positive results of ultrasound and MRE. Therapeutic change was suggested in only 18 patients. Conclusions: Ultrasound should be performed by an experienced examiner, and a proctological examination should be added. MRE is justified in cases of discrepancy between clinical findings and the results of diagnostic ultrasound and, moreover, if Crohn's lesions are suspected at sites proximal to the terminal or neoterminal ileum.
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ing accepted more and more as the first-line modality for the evaluation of suspected inflammatory bowel disease [1] [2] [3] [4] [5] . Ultrasound as a widely available, non-radiation examination can be performed for assessment of bowel wall abnormalities and complications of Crohn's disease such as fistulas and abscesses [6, 7] . Due to increased vascularization in inflammation, an enhanced Doppler signal can be found; however, these changes in wall vascularity visualized by Doppler techniques [4, 8, 9] show no clear correlation with clinical or biological scores [6, 10] . Some suggest MRE to be superior to ultrasound, particularly regarding the localization of affected bowel segments and the detection of fistulas [11] . Other studies showed a good comparability between the results of MR enterography and ultrasound [12] [13] [14] .
It has to be kept in mind that in all these studies ultrasound was performed by a very experienced examiner being engaged only with the object of the study and not being subjected to any time pressure regarding the examination. The aim of our study was to analyze in how many cases a MRE compared with a routine ultrasound done in an interdisciplinary center of clinical ultrasound (3 examiners, 60-80 ultrasound examinations a day) during normal working time without any special conditions leads to a change in a therapeutic decision. In other words, how good is ultrasound under 'real working conditions' and what are the implications?
Material and Methods
We retrospectively evaluated findings of MRE and ultrasound in 47 in-and outpatients (21 males, 26 females, mean age 31.8 8 11.4 years) with previously diagnosed Crohn's disease who underwent ultrasound as well as MRE. Routine B-scan and Doppler ultrasound were performed with a linear 7.5-MHz transducer (Elegra, Siemens, Germany; Logiq 9, General Electric, USA) carried out by one of three examiners in our interdisciplinary center of clinical ultrasound (60-80 ultrasound examinations a day) during working time (08.00 until 17.00 h) without any special conditions. Bowel wall thickening ( 1 3 mm) with hyperperfusion to a greater or lesser extent suggested affection by Crohn's disease. Additionally, all patients received MRE in the 'dark lumen' technique as described elsewhere [15] . Image evaluation was performed by two experienced radiologists in consensus by means of bowel wall thickening and increased contrast uptake of the bowel wall. The examiners were blinded to the results of the other imaging modality. Delay between the two examinations was 5.8 8 7.0 days in all 47 patients. Thereafter, actual medical history, complete blood count, C-reactive protein (CRP) and sonographic Bscan findings were independently assessed by two board-certified physicians with extended experience in the diagnosis and therapy of Crohn's disease. No relevant therapeutic actions, such as administration of high dose steroids or anti-TNF agents, were taken between the performances of ultrasound and MRE, respectively. Based on these examinations, the two specialists retrospectively provided a therapeutic concept. Thereafter, the physicians were additionally given the results of the MRE, and they had to provide a new proposal of therapy regarding all the information available (current medical history, complete blood count, CRP (normal value ! 5 mg/l), results of B-scan ultrasound with Doppler and results of MRE). Considering the results of MRE, possible criteria for a change in therapeutic proposal were a change in the feature 'localization' of the Montreal classification (L1 ileal, L2 colonic, L3 ileocolonic, L4 isolated upper gastrointestinal tract, L4 + L1/ L2/L3 upper and L1/L2/L3) and a newly diagnosed abscess. Regarding these criteria, one has to keep in mind that -due to information about clinical presentation and preexisting therapynot every additional information from MRE leads to another therapeutic proposal. Since neither a transrectal ultrasound nor a magnetic resonance imaging of the pelvis -each the method of choice for the detection of pararectal fistulas -were performed in our study, we did not regard pararectal fistulas. The ethics committee at the University of Regensburg approved the study.
Results

Ultrasound Findings and Their Correlation with the Results of the MR Examinations
Sonographically, the most frequent affected bowel segments were found in the ileum and the terminal ileum -representing the preferential site of Crohn's disease. 17 of 19 findings in the ileum were confirmed by MRE. The right and the left colon were the second most frequent affected sites, and MRE could reproduce all sonographic findings in these segments. The only case of inflammation of the jejunum detected by ultrasound was not confirmed by MRE. Ultrasound did not identify any inflammation of the rectum in the 47 patients. In one case, sonographic findings showed an abscess ( fig. 1 ).
Correlation of MRE Assessment with Ultrasound Findings of the Corresponding Sites
Affection of the ileum was seen 31 times by MRE; however, only 17 cases of them could also be identified by ultrasound. Ultrasound could not detect any of the jejunal segments affected according to MRE (0/3), furthermore, no rectal (0/7) affection. Seven abscesses were diagnosed by MRE, but only one abscess was seen by ultrasound ( fig. 2 ). Six patients suffering from abscesses had clearly elevated inflammation markers (CRP 1 50 mg/l), but only 1 of them presented with fever. The seventh patient had no fever, but showed a CRP value of only 30.69 mg/l; however, the abscess was only about 1 cm in size (see below).
Correlation of Imaging Results with CRP Levels
With increasing CRP values, we observed an increasing number of positive ultrasounds and positive MREs. Two patients with a CRP value 1 70 mg/l and no evidence of a manifestation of Crohn's disease at MRE and bowel ultrasound suffered from pancreatitis while taking azathioprine, and urosepsis with underlying nephrolithiasis, respectively. The third patient with normal ultrasound and CRP 1 70 mg/l showed an ileitis and an abscess on MRE.
In contrast, there were 6 patients with unremarkable CRP values, but positive findings in MR examinations. These patients were treated with high-dose systemic corticosteroids (n = 2), budesonide (n = 1), azathioprine plus budesonide (n = 1) or azathioprine plus steroids (n = 1), and certolizumab (n = 1), respectively ( fig. 3 ) . No abscesses were detected with CRP levels below 20 mg/l; the only 2 patients with CRP ! 70 mg/dl and an abscess had CRP values of 58.53 mg/l (with methotrexate) and 30.69 mg/l (without immunosuppressive therapy), respectively ( fig. 4 ) . However, the latter abscess was only about 1 cm in size. Three of the abscesses missed by sonography were localized in the pararectal or the perianal region, and one further abscess was seen to be only about 1 cm in size at MRI.
Change of Known Bowel Involvement Pattern as a Consequence of MRE Findings
Since therapeutic implications may arise from a change in knowledge of the pattern of bowel involvement, we analyzed this in our patients. In 24 cases, additional information from MR examinations resulted in a relevant change in the knowledge of affected bowel segments followed by a change of placement according to the Mon- 
Therapeutic Implications Arising from MR Examinations
The initial interobserver variability was calculated. There was an observed interobserver agreement of 89% with = 0.76 representing a substantial agreement between the specialists. The specialists discussed the 5 cases in which their assessment differed and reached agreement regarding their therapeutic proposals. Thus, in 18 of the total 47 patients (38%), a change in therapeutic strategy was necessary based on the findings of MR examinations. Ultrasound was negative concerning Crohn's lesions 11 times, despite clinical findings suggestive of activity (e.g. pain, diarrhea), but MRE demonstrated bowel inflammation. An abscess found by MRE led to another therapeutic approach 4 times, and MRE diagnosed a more extended bowel involvement with Crohn's disease affecting either more or other bowel segments than ultrasound, causing a change in treatment strategy 3 times.
Discussion
Due to its characteristic as a chronic remitting and relapsing disease, patients with Crohn's disease again and again suffer from diarrhea and abdominal pain. These complaints are not always caused by bowel inflammation, but can also be based on Crohn's disease-associated affections such as (drug-induced) pancreatitis (azathioprine) or other non-Crohn's disease-related illnesses such as infectious gastroenteritis, nontropical sprue, urinary tract infection, gynecological disorders, and many more. Thus, besides clinical examinations and laboratory tests, patients with Crohn's disease often have to undergo several imaging studies in order to find the most suitable therapeutic approach. Ultrasound and MRE are the diagnostic imaging techniques of choice in the mostly young Crohn's disease patients since they are not associated with the exposure to irradiation, particularly as they are noninvasive.
Bowel wall ultrasound is an elegant method for clinical follow-up in patients with Crohn's disease. But it is known to have some limitations; thus, Schober et al. [16] recommend that ultrasound should be supplemented in both the primary diagnosis and follow-up with methods such as endoscopy and complementary imaging.
The reported ranges of ultrasound sensitivity and specificity for the diagnosis of Crohn's disease are 75-94 and 67-100%, respectively [17] ; the values of MRI sensitivity and specificity for the diagnosis of Crohn's diseaserelated lesions range from 78 to 100% for both [18, 19] . A number of studies have been done comparing ultrasound and MRE with divergent results. Some studies showed a good comparability between the results of MRE and ultrasound, in some ultrasound was even superior [12] [13] [14] 20] . Others suggested that MRE was superior to ultrasound, particularly regarding the localization of affected bowel segments and the detection of fistulas [11] .
Similar to the results of Pascu et al. [13] , evaluation of the rectum was not successful using ultrasound, whereas assessment by MRE was uncomplicated. Moreover, in our study, MRE detected far more inflamed bowel segments than did ultrasound. However, ultrasound assessment of the anatomically fixed bowel parts such as the terminal ileum and left colon showed good recognition by MRE, suggesting a good reliability of sonographically detected pathological findings of these bowel regions. Similar results were presented by Potthast et al. [11] who showed bowel wall ultrasound to have a high sensitivity (85%) for recognizing involvement of the terminal or neoterminal ileum and a significantly lower sensitivity (50%) for the evaluation of more proximal bowel segments. They attributed their findings to the fact that topographic orientation proximal to the terminal or neoterminal ileum is difficult with ultrasound.
We found an increasing number of positive ultrasounds and MR examinations with increasing CRP values. On the other hand, there were 2 patients who complained of abdominal pain with a CRP value 1 70 mg/l who had no evidence of manifestation of Crohn's disease, but suffered from other diseases (pancreatitis and urosepsis based on nephrolithiasis). Also, there were 6 patients with unremarkable CRP values, but positive findings in MRE. All of these patients were treated with immunosuppressive drugs. Thus, we can conclude that CRP may provide an indication of an acute episode of Crohn's disease, but other causes have to be considered. Furthermore, patients on immunosuppressive drugs can suffer from an acute episode of Crohn's disease or abscess despite normal CRP values.
In our collective, we only found seven abscesses at MRE, and only one of them could be identified at ultrasound. Three of the six abscesses which were not detected by sonography were found in the perirectal/perianal region. Obviously, this region is difficult to assess reliably by transabdominal sonography; however, a transrectal sonography might have captured these three perirectal/ perianal abscesses. A further abscess was only about 1 cm in size. Hence, the markedly good specificity (92-94%) and sensitivity (87-100%) of ultrasound in the detection of abscesses reported by Potthast et al. [11] , Maconi et al. [21] and Gasche et al. [22] can hardly refer to pararectal abscesses. In about half (n = 24) of our patients, a change in the knowledge of the involvement pattern was evident after MRE, this led to a change in therapeutic strategy as suggested by the specialists in only 16 of these patients. Overall, in 18 patients, the specialists provided a therapeutic change, the reason being -besides the above-mentioned change of the involvement pattern -the detection of abscesses in 4 cases (in 2 patients double finding of involvement pattern and abscess). However, MRE revealed rectal involvement in 7 patients, none of which were identified by ultrasound. The rectal involvement led to a change in the Montreal classification in 4 patients and to a change of therapeutic strategy proposed by the specialists in 3 patients. Thus, if transabdominal ultrasound would have been supplemented by proctoscopy, additional information from MRE concerning the involvement pattern (Montreal classification) could be assumed in only 22 patients, and a change of therapeutic proposal due to this additional information would have been made in only 14 patients. Moreover, if additional transrectal sonography would have been performed, the three perirectal/perianal abscesses could have been identified.
A limitation of our study is the lack of a reference standard and, hence, the validation of the ultrasound and MRE findings, respectively. Conventional enteroclysis and endoscopy represent the Goldstandard for diagnosis and evaluation of Crohn's disease concerning intraluminal changes; however, assessment of the transmural or extramural extent or extraintestinal complications is limited. Laparotomy as reference standard for extraluminal manifestations was not performed. Further studies comparing the capabilities of bowel wall ultrasound and MRE by using a reference standard will be required to confirm the findings of the present study.
Based on our results, we suggest -similar to Potthast et al. [11] -the following procedure in the assessment of bowel involvement in Crohn's disease: ultrasound should be performed by an experienced examiner, but in any case, a proctological examination should be added. MRE is justified in cases of discrepancy between clinical findings and/or laboratory tests and the results of diagnostic ultrasound. Magnetic resonance imaging is also useful in the diagnosis of intra-abdominal abscesses. Finally, MRE should be performed if Crohn's lesions are suspected at sites proximal to the terminal or neoterminal ileum.
